摘要
目的:构建猪传染性胃肠炎病毒S蛋白的细胞内表达重组乳酸乳球菌,确定其最佳表达条件,为重组乳酸菌作为口服疫苗防治猪传染性胃肠炎奠定基础。方法:根据猪传染性胃肠炎病毒纤突(S)蛋白的全基因序列及表达载体质粒的基因融合特点,设计一对引物,进行PCR,获得含有TGEVS基因4个主要抗原位点的约2000bp目的片段,将其与表达载体质粒pNZ8048进行连接,通过电转化进入宿主菌乳酸乳球菌NZ9000细胞内,在乳链菌肽(Nisin)的诱导下进行表达,确定最佳表达条件;并通过SDS-PAGE进行检测和Western-blot分析表达蛋白活性。结果:成功获得了TGEVS蛋白在乳酸乳球菌细胞内的表达并且表达的蛋白具有TGE全病毒的抗原性。确定了乳酸乳球菌表达TGEVS蛋白的最佳表达条件为在以1ng/ml的乳链杆菌肽nisin诱导下,诱导后3h,重组蛋白表达效率达最高,重组蛋白约占菌体总蛋白含量的8.7%。结论:在乳酸乳球菌细胞内表达的重组TGEVS蛋白获得了理想表达,为进一步研制开发防治TGE口服疫苗提供物质基础。
Objective: Recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis coronavirus (TGEV) spike glycoprotein S was constructed and decided the optimum expression condition. It had established base for recombinant LactobaciUus as vaccine preventing and curing TGE. Methods: The gene of S Glycoprotein was cloned into a Lactococcus lactis vector pNZ8048. An appro:dmately 2000bps fragmemt of TGEV gene S that encompasses all the four major antigenic domains critical for neutralization was transformed into Lactococcus lactis NZ9000 by electroporation, resulting in recombinant strain pNZ8048- S/NZ9000. The recombinant intracellular glycoprotein S was detected by SDS- PAGE and Western - blot after induced by 1ng/ml nisin. The effect of different inducing time and different concentration of the inducer on the expression product was detected. Results: The result indicated that the expressed product maintain antigenicity of TGEV as we expected. The recombinant glycoprotein S, the mount of which can be reached approximately 8.7% of the total bacteria protein evaluated by densitometric scanning, was detected by SDS - PAGE after induced by 1 ng/ml nisin. The expression efficiency achieved tiptop after 3 hours induced by 1 ng/ml nisin. Conclusion: The recombinant TGEV S protein was achieved expressed in Lactococcus lactis and had established base for developing oral vaccine preventing and curing TGE.
出处
《生物技术》
CAS
CSCD
2007年第6期4-8,共5页
Biotechnology
基金
国家自然科学基金面上项目资助(30371074)
关键词
TGEV
S蛋白
乳酸菌
表达及分析
TGEV S glycoprotein
Lactobacillus
expression and analysis